Lilly: Arxxant cuts sight loss in diabetes
13th Nov 2006, 19:47 GMT
U.S. firm Eli Lilly said Monday its drug to be sold as Arxxant, cuts vision loss in patients with moderate/severe diabetic retinopathy.
Lilly: Arxxant cuts sight loss in diabetes related news:
- Lilly: Arxxant Cuts Sight Loss in Diabetes — RedOrbit News - Health
- Lilly drug reduces blindness in diabetic patients — Pharmaceutical Business Review Latest News
- Weight Loss Surgery Assists in Eliminating, Avoiding Type 2 Diabetes; American Institute of Gastric Banding Recognizes November as Nat'l Diabetes Month — Nephrology/ Dialysis News from StratCenter.com
- Goat Riders of the Apocalypse :: Goat Riders: Hot Stove: Cubs contact Lilly, interested in Soriano — Sports Blogs :: Chicago Cubs Daily Entries
- Lampert Smith: Politics will be less colorful with these characters gone — madison.com - RSS
- Eli Lilly and Company Foundation To Fund World-Class Diabetes Treatment and Care Program at Riley Hospital for Children — PR Newswire: All Releases
- Shermag cuts loss amid restructuring — thestar.com: Breaking News
- On World Diabetes Day, American Diabetes Assoc Advocates for Greater Health Care Access and Affordability — Nephrology/ Dialysis News from StratCenter.com
- Evangeline Lilly predicts Jolie to be the first female US Prez! — NewKerala Hollywood News
- Diabetes 'hitting poor hardest'. — Environmental Health News
Latest news from United Press International - Health Business:
- AmerisourceBergen tests Rx tracking plan
- Merck: Arcoxia heart risk same as Voltaren
- Corcept tests psych. major depression Rx
- Neurogen's obesity drug in phase 1 trial
- Analysis: Insurance horizons expanding
- Dendreon seeks OK for Provenge
- Robots caring for stroke patients
- Diabetes drug stalls heart disease
- Diabetes drug also helps arteries
- Promising vaccine for early breast cancer